Nanoscale radiotherapy with hafnium oxide nanoparticles

Area of Science:

• Nanotechnology
• Radiotherapy
• Oncology

Background:

• Improving the therapeutic window of radiotherapy is crucial for cancer treatment.
• High-atomic-number nanoparticles can enhance radiation dose deposition in tumor cells.

Purpose of the Study:

• To design hafnium oxide nanoparticles for targeted intracellular high-energy dose deposit in tumor cells.
• To explore the interactions of these nanoparticles with ionizing radiation in biological systems.

Main Methods:

• Conventional methods were employed to study nanoparticle-radiation interactions.
• Monte Carlo simulations were used to assess radiation dose enhancement.
• Human cancer models were utilized to evaluate antitumor activity and safety.

Main Results:

• Hafnium oxide nanoparticles demonstrated a ninefold radiation dose enhancement compared to water.
• Nanoparticles showed satisfactory dispersion and persistence within tumors, clustering in cancer cell cytoplasm.
• Significant antitumor activity was observed in human cancer models.
• Toxicology evaluation indicated similar safety profiles in treated and control animals.

Conclusions:

• Hafnium oxide nanoparticles show promise as an anticancer therapeutic approach.
• The observed dose enhancement and antitumor activity, coupled with good tolerance, support clinical development.
• This novel nanoparticle-based strategy offers a potential improvement in radiotherapy for cancer patients.